항-GQ1b 항체증후군; Miller Fisher 증후군의 다른 이름인가, 새로운 증후군의 출현인가?

키워드

참고문헌 (50)

1. Parry GJ, "Guillain-Barré syndrome. 1st ed", pp.34~35 (2007), Demos Medical Publishing
2. Fisher M, "An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)", N Engl J Med, 255, pp.57~65 (1956)
3. Bickerstaff ER, "Mesencephalitis and rhombencephalitis", Br Med J, 2, pp.77~81 (1951)
4. Bickerstaff ER, "Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis", Br Med J, 1, pp.1384~1387 (1957)
5. Odaka M, "Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barre syndrome", Brain, 126, pp.2279~2290 (2003)
6. Na JG, "Brainstem encephalitis mimicking Miller Fisher syndrome", J Korean Neurol Assoc, 12, pp.758~763 (1994)
7. Kim BJ, "Relapsing sensory ataxia initially manifested by Miller Fisher syndrome", J Korean Neurol Assoc, 15, pp.216~221 (1997)
8. Hong SN, "A case of Miller Fisher syndrome presenting as sudden vertigo", J Korean Neurol Assoc, 18, pp.486~489 (2000)
9. 구대림, "항 GQ1b 항체와 연관된 급성 단안성 외안근마비", 대한신경과학회지, 22(6), pp.663~665 (2004), 대한신경과학회
10. Chiba A, "Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome", Ann Neurol, 31, pp.677~679 (1992)
11. Lo YL, "Clinical and immunological spectrum of the Miller Fisher syndrome", Muscle Nerve, 36, pp.615~627 (2007)
12. Ito M, "Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases", J Neurol, 255, pp.674~682 (2008)
13. Odaka M, "Anti-GQ1b IgG antibody syndrome: clinical and immunological range", J Neurol Neurosurg Psychiatry, 70, pp.50~55 (2001)
14. Mori M, "Clinical features and prognosis of Miller Fisher syndrome", Neurology, 56, pp.1104~1106 (2001)
15. Chiba A, "Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies", Neurology, 43, pp.1911~1917 (1993)
16. Chiba A, "Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome", Brain Res, 745, pp.32~36 (1997)
17. Kusunoki S, "Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia", Muscle Nerve, 22, pp.1071~1074 (1999)
18. Mori M, "IgG anti-GQ1b positive acute ataxia without ophthalmoplegia", J Neurol Neurosurg Psychiatry, 67, pp.668~670 (1999)
19. Sandhoff K, "Ganglioside metabolism: enzymology, topology and regulation", Prog Brain Res, 101, pp.17~29 (1994)
20. Svennerholm L, "Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord", Biochim Biophys Acta, 1214, pp.115~123 (1994)
21. Malisan F, "GD3 ganglioside and apoptosis", Biochim Biophys Acta, 1585, pp.179~187 (2002)
22. Hakomori S, "Glycosphingolipid antigens and cancer therapy", Chem Biol, 4, pp.97~104 (1997)
23. Yu RK, "Development regulation of ganglioside metabolism", Prog Brain Res, 101, pp.31~44 (1994)
24. Nagai Y, "Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides", Neurosci Lett, 2, pp.107~111 (1976)
25. Ilyas AA, "Serum antibodies to gangliosides in Guillain- Barre syndrome", Ann Neurol, 23, pp.440~447 (1988)
26. van den Berg LH, "Anti-GM1 antibodies in patients with Guillain-Barre syndrome", J Neurol Neurosurg Psychiatry, 55, pp.8~11 (1992)
27. Yuki N, "Axonal degeneration in the Guillain-Barre syndrome and anti-GM1 ganglioside antibodies", Muscle Nerve, 15, pp.116~ (1992)
28. Yuki N, "Severe acute axonal form of Guillain-Barre syndrome associated with IgG anti-GD1a antibodies", Muscle Nerve, 15, pp.899~903 (1992)
29. Kusunoki S, "N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barre syndrome", Ann Neurol, 35, pp.570~576 (1994)
30. Koga M, "Is IgG anti- GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barre syndrome?", J Neuroimmunol, 86, pp.74~79 (1998)
31. Nakamura K, "Anti-GM2 antibodies in Guillain-Barre syndrome with acute cytomegalovirus infection", Ann N Y Acad Sci, 845, pp.423~ (1998)
32. Kusunoki S, "Localization of GM1 and GD1b antigens in the human peripheral nervous system", Muscle Nerve, 16, pp.752~756 (1993)
33. Yuki N, "Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain- Barre syndrome?", Acta Neurol Scand, 102, pp.1332~134 (2000)
34. Yuki N, "Ataxic Guillain-Barre syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome", Neurology, 54, pp.1851~1853 (2000)
35. Yuki N, "Successful plasmapheresis in Bickerstaff's brain stem encephalitis associated with anti-GQ1b antibody", J Neurol Sci, 131, pp.108~110 (1995)
36. Kusunoki S, "Experimental sensory neuropathy induced by sensitization with ganglioside GD1b", Ann Neurol, 39, pp.424~431 (1996)
37. Hahn AF, "Guillain-Barre syndrome", 352, pp.635~641 (1998)
38. Hughes RA, "Guillain-Barre syndrome", Lancet, 366, pp.1653~1666 (2005)
39. Neisser A, "Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome", Infect Immun, 65, pp.4038~4042 (1997)
40. Yuki N, "Bacterial infections in Guillain-Barre and Fisher syndromes", Curr Opin Neurol, 19, pp.451~457 (2006)
41. Lee SH, "Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody", Neurology, 71, pp.426~429 (2008)
42. Bae JS, "Bilateral internal ophthalmoplegia as an initial sole manifestation of Miller Fisher syndrome", J Clin Neurosci, 16, pp.963~964 (2009)
43. 김종국, "내안근마비를 동반한 항GQ1b 항체증후군 3예", 대한신경과학회지, 25(1), pp.115~118 (2007), 대한신경과학회
44. Willison HJ, "Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies", Eur J Neurol, 6, pp.71~77 (1999)
45. Irie S, "Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barre syndrome: comparison with ELISA", Intern Med, 42, pp.490~495 (2003)
46. Susuki K, "Fine specificity of anti-GQ1b IgG and clinical features", J Neurol Sci, 185, pp.5~9 (2001)
47. Kim JK, "Correlatioins of anti-ganglioside antibodies with ophthalmoparesis in Miller Fisher syndrome and Guillain-Barré syndrome", J Peripher Nerv Syst, 13, pp.172~ (2008)
48. Nagashima T, "Clinical correlates of serum anti-GT1a IgG antibodies", J Neurol Sci, 219, pp.139~145 (2004)
49. Kaida K, "Anti-ganglioside complex antibodies in Miller Fisher syndrome", J Neurol Neurosurg Psychiatry, 77, pp.1043~1046 (2006)
50. Kanzaki M, "Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes", J Neurol Neurosurg Psychiatry, 79, pp.1148~1152 (2008)

관련 논문AI추천